Novel and Proven Models of Public, Private, and Public–Private Partnerships in Healthcare: An Update
- 28 August 2024
- book chapter
- Published by Springer Nature
- p. 1-19
Abstract
Initiatives to share assets in the life science sector through dedicated partnerships had and still have a multitude of different aspects in the past few decades. The range goes from industry partners, small and big companies, in bilateral agreements with academic institutions up to large privately and publicly funded consortia. In general, the term public–private partnership (PPP) is used when at least one public (non-profit, academic, and/or government) part and one or more private for-profit partners are involved. A Public-Private Partnership is often driven by a public body, i.e. a ministry or a public agency. Their synergism has been described 10 years ago (Dearing, Science 315(19):344–347, 2007; Casty and Wieman, Ther Innov Regul Sci 47(3):375–383, 2013; Stevens et al., Biotechnol Law Rep 34(4):153–165, 2015). So why view this synergism again today? It will be shown that the situation in life science has changed: novel partners acting digital, data expertise being involved on many levels and novel partnering models arising. Success and challenges will be described in this chapter.Keywords
This publication has 31 references indexed in Scilit:
- A Nationwide Network of Health AI Assurance LaboratoriesJAMA, 2024
- A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritizationCancer Cell, 2024
- Genetic support for FDA-approved drugs over the past decadeNature Reviews Drug Discovery, 2023
- Challenges of artificial intelligence in precision oncology: public-private partnerships including national health agencies as an asset to make it happenAnnals of Oncology, 2023
- The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovationThe Lancet, 2023
- Genome- and metabolome-guided discovery of marine BamA inhibitors revealed a dedicated darobactin halogenaseCell Chemical Biology, 2023
- The Relative Contributions of NIH and Private Sector Funding to the Approval of New BiopharmaceuticalsTherapeutic Innovation & Regulatory Science, 2022
- Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligenceAcademic Pathology, 2022
- Health information technology and digital innovation for national learning health and care systemsThe Lancet Digital Health, 2021
- Public-Private Partnership Models for Science, Technology, and Innovation CooperationJournal of the Knowledge Economy, 2015